Conditions: Herpes Simplex
Keywords: Infants, Herpes simplex infection
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 18
Healthy volunteers: no

Brief summary:
This study will evaluate the acceptability and safety of famciclovir in infants with herpes simplex infection

Detailed description:

Arms:
arm 1: Famciclovir was administered orally as a suspension in OraSweet® on Day 1. Patients received a single, individualized dose between 25-200 mg based on body weight.

Interventions: intervention 1: famciclovir
Intervention descriptions: intervention 1: Administered orally as a single individualized dose between 25-200 mg based on body weight.

Protocol document: